Skip to main content
. 2013 Sep;15(9):1049–1063. doi: 10.1593/neo.13286

Table 1.

MDM2-ALT1.

Characteristic MDM2-ALT1 Present, n (%) MDM2-ALT1 Absent, n (%) P Value (Fisher Exact Test)
IRSG stage
I 4 (14.3%) 6 (30%) .0043
II 6 (21.4%) 1 (5%)
III 7 (25%) 12 (60%)
IV 11 (39.3%) 1 (5%)
RMS risk level
Low 4 (13.8%) 5 (25%) .0288
Intermediate 14 (48.3%) 14 (70%)
High 11 (37.9%) 1 (5%)
n (Estimated Survival %) n (Estimated Survival %) P Value (Log-Rank Test)
Survival (5 years)
Low risk 4 (66.7%) 5 (100%) .2395
Intermediate risk 14 (71.4%) 14 (74.1%)
High risk 11 (67.5%) 1 (100%)